Postpartum patients have slightly prolonged neuromuscular block after mivacurium

Anesthesia and Analgesia

Volumn 86, Issue 1, 1998, Pages 82-85

  Gin, Tony ^a,b   Derrick, James L ^a   Chan, Matthew T V ^a   Chui, Po Tong ^a   Mak, Tony W L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; FENTANYL; MIVACURIUM; NITROUS OXIDE; PROPOFOL;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ELECTROMYOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROMUSCULAR BLOCKING; PHOTOMETRY; PRIORITY JOURNAL; PUERPERIUM; UTERINE TUBE LIGATION;

ADULT; FEMALE; HUMANS; ISOQUINOLINES; MIDDLE AGED; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTPARTUM PERIOD; PREGNANCY; TIME FACTORS;

EID: 0031974978     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199801000-00016     Document Type: Article

References (17)

1. Basta SJ. Clinical pharmacology of mivacurium chloride: a review. J Clin Anesth 1992;4:153-63.
2. Viby-Mogensen J. Mivacurium block in patients with abnormal plasma cholinesterase. Acta Anaesthesiol Scand 1995;39:1001-2.
3. Whittaker M. Plasma cholinesterase variants and the anaesthetist. Anaesthesia 1980;35:174-97.
4. Evans RT, Wroe JM. Plasma cholinesterase changes during pregnancy. Anaesthesia 1980;35:651-4.
5. Leighton BL, Cheek TG, Gross JB, et al. Succinylcholine pharmacodynamics in peripartum patients. Anesthesiology 1986;64: 202-5.
6. Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40: 59-74.
7. Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage: implications for drug therapy. Clin Pharmacokinet 1994;26:292-307.
8. Das PK, Liddel J. Value of butyrylthiocholine assay for identification of cholinesterase variants. J Med Genet 1970;7:351-5.
9. Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase: determination of dibucaine numbers. Can J Biochem Physiol 1957;35:339-46.
10. Harris H, Whittaker M. Differential inhibition of human serum cholinesterase with fluoride. Recognition of two new phenotypes. Nature 1961;191:496-8.
11. McCoy EP, Mirakhur RK, Connolly FM, Loan PB. The influence of the duration of control stimulation on the onset and recovery of neuromuscular block. Anesth Analg 1995;80:364-7.
12. Østergaard D, Jensen FS, Jensen E, et al. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 1992;36:702-6.
13. Erkola O, Rautoma P, Meretoja OA. Interaction between mivacurium and succinylcholine. Anesth Analg 1995;80:534-7.
14. Camp CE, Tessem J, Adenwala J, Joyce TH III. Vecuronium and prolonged neuromuscular blockade in postpartum patients. Anesthesiology 1987;67:1006-8.
15. 2-receptor antagonist premedication on the duration of vecuronium-induced neuromuscular blockade in postpartum patients. Anesthesiology 1989;71:175-7.
16. Khuenl-Brady KS, Koller J, Mair P, et al. Comparison of vecuronium-and atracurium-induced neuromuscular blockade in postpartum and nonpregnant patients. Anesth Analg 1991; 72:110-3.
17. Pühringer FK, Sparr HJ, Mitterschiffthaler G, et al. Extended duration of action of rocuronium in postpartum patients. Anesth Analg 1997;84:352-4.